ArticleAging2023

ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network.

Hongyan Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.